We found that the relative mRNA and protein expression NF-κB signal pathway (PI3K, AKT, mTOR, NF-κB) decreased (p<0.05) with down-regulation Tim3 of MM cells, suggesting that Tim3 may be a potential therapeutic target. Here, HAVCR2 is linked to Miyoshi myopathy.